Gaush Meditech Ltd (FRA:F7Y)

Germany · Delayed Price · Currency is EUR

0.4900

-0.0040 (-0.81%)

Last updated: Aug 26, 2026, 8:01 AM CET

-38.75% (1Y)

Market Cap	72.86M -38.7%
Revenue (ttm)	168.08M -3.4%
Net Income	11.71M +4.1%
EPS	0.08 +6.0%
Shares Out	n/a
PE Ratio	6.22
Forward PE	n/a
Dividend	0.03 (6.77%)
Ex-Dividend Date	Jun 23, 2025

Volume	n/a
Open	0.4900
Previous Close	0.4940
Day's Range	0.4900 - 0.4900
52-Week Range	0.4820 - 1.1200
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Gaush Meditech

Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refrac... [Read more]

Industry Medical, Dental, and Hospital Equipment and Supplies

Founded 1998

Employees 893

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol F7Y

Financial Performance

In 2025, Gaush Meditech's revenue was 1.38 billion, a decrease of -3.36% compared to the previous year's 1.43 billion. Earnings were 96.19 million, an increase of 4.11%.

Financial numbers in CNY Financial Statements